GlassScriptPhysician profile
Aysha Agarwal
NPI 1033564026
$1,858.69
in general payments reported to CMS, 2019-2025
14 companies · $48.53 in 2025
The $48.53 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2021: $277 · 2022: $511 · 2023: $871 · 2024: $28.52 · 2025: $48.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $606 · Food and Beverage: $342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $606.16 |
| Food and Beverage | $341.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pulmonx Corporation | $740.71 | 2022-2023 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Olympus America INC. | $305.25 | 2021-2022 | |
| United Therapeutics Corporation | $160.72 | 2022-2023 | Tyvaso, Remodulin, Orenitram |
| Astrazeneca Pharmaceuticals LP | $137.86 | 2021-2023 | Tezspire |
| Mylan Specialty L.P. | $123.26 | 2019 | |
| Grifols USA, LLC | $112.13 | 2022 | |
| Intuitive Surgical, INC. | $99.24 | 2022 | |
| Merck Sharp & Dohme LLC | $40.90 | 2022-2023 | Delstrigo, Dificid, Pifeltro |
| Abiomed | $28.52 | 2024 | Impella |
| Actelion Pharmaceuticals US, INC. | $28.06 | 2023 | Uptravi |
| Viatris Specialty LLC | $24.48 | 2025 | Yupelri |
| Genzyme Corporation | $24.05 | 2025 | |
| Shionogi INC | $17.68 | 2023 | Fetroja |
| Paratek Pharmaceuticals, INC. | $15.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aysha Agarwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.